The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

“As the first virus-like particle single-dose, pre-filled syringe chikungunya vaccine, Vimkunya provides a crucial new tool to help protect at-risk individuals traveling to regions where the ...

The global animal vaccines market was valued at $9,093.9 million in 2020, and is projected to reach $13,780.6 million by 2028, registering a CAGR of 5.3% from 2021 to 2028. The market is expected to ...

Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have received an average recommendation of “Buy” from the seven ...

Measles is so infectious that when under-vaccinated individuals mingle, they'll always be at risk. That's why public health ...

Low-cost, DIY air purifiers are proving to be just as effective as expensive commercial units at protecting indoor spaces ...

During a call between U.S. President Donald Trump and his Ukrainian counterpart, the U.S. leader apparently suggested ...

Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...

This illustration provides a 3D graphical representation of a spherical-shaped, measles virus particle ... include vulnerable populations — like infants who are too young to be vaccinated ...